Cargando…
Tumour Cannabinoid CB(1) Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer
BACKGROUND: In cultured prostate cancer cells, down-regulation of epidermal growth factor receptor (EGFR) has been implicated in mediating the antiproliferative effect of the endogenous cannabinoid (CB) ligand anandamide. Using a well-characterised cohort of prostate cancer patients, we have previou...
Autores principales: | Fowler, Christopher J., Hammarsten, Peter, Bergh, Anders |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009725/ https://www.ncbi.nlm.nih.gov/pubmed/21203460 http://dx.doi.org/10.1371/journal.pone.0015205 |
Ejemplares similares
-
Association between Cannabinoid CB(1) Receptor Expression and Akt Signalling in Prostate Cancer
por: Cipriano, Mariateresa, et al.
Publicado: (2013) -
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB(1) Receptor Expression and Regulation by IL-4
por: Thors, Lina, et al.
Publicado: (2010) -
Increased Expression of Cannabinoid CB(1) Receptors in Achilles Tendinosis
por: Björklund, Emmelie, et al.
Publicado: (2011) -
Cannabinoid 1 (CB(1)) receptor arrestin subtype‐selectivity and phosphorylation dependence
por: Manning, Jamie J., et al.
Publicado: (2022) -
Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)